OxyContin maker will stop promoting opioids to doctors

February 10, 2018
OxyContin maker will stop promoting opioids to doctors
This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. The maker of the powerful painkiller said it will stop marketing opioid drugs to doctors, a surprise reversal after lawsuits blaming the company for helping trigger the current drug abuse epidemic. OxyContin has long been the world's top-selling opioid painkiller and generated billions in sales for privately-held Purdue. (AP Photo/Toby Talbot, File)

The maker of the powerful painkiller OxyContin said it will stop marketing opioid drugs to doctors, a surprise reversal following lawsuits that blamed the company for helping trigger the current drug abuse epidemic.

OxyContin has long been the world's top-selling opioid painkiller. It generated billions in sales for privately-held Purdue.

The pill, a time-release version of oxycodone, was hailed as a breakthrough treatment for when it was approved in late 1995. But some users quickly discovered they could get a heroin-like high by crushing the pills and snorting or injecting the entire dose at once.

Purdue's promotions exaggerated the drug's safety and risks of addiction, leading to and federal investigations. But the drug continued to rack up blockbuster sales.

Explore further: FDA panel: Not enough data to OK "abuse-deterrent" opioid

Related Stories

FDA panel: Not enough data to OK "abuse-deterrent" opioid

July 26, 2017
A panel of Food and Drug Administration advisers voted against approving a new opioid painkiller with a unique feature for deterring abuse: It releases a deep-blue dye if someone tries to get high by crushing, chewing or ...

Alabama files lawsuit against opioid manufacturer

February 6, 2018
Alabama on Tuesday filed a lawsuit against the manufacturer of OxyContin and other opioids, becoming the latest state seeking to hold drug companies accountable for an addiction epidemic.

Fearing abuse, US blocks generic OxyContin (Update)

April 16, 2013
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.

US city sues maker of painkiller OxyContin

January 20, 2017
A small US city on Thursday filed a lawsuit against Purdue Pharma, the maker of the pain reliever OxyContin, accusing the company of helping fuel an opioid crisis that has devastated the town.

OxyContin maker bows out of meeting on harder-to-abuse drug

June 30, 2015
The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug.

Recommended for you

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gzurbay
not rated yet Feb 10, 2018
Nothing like permitting a company to close the barn door after all the horses are out and the scamming of sales way in excess of the prescription need have flourished and established a presence in the medical system. Why should society not demand criminal punishment for what has been done with total lack of self oversight?? As always white collar crime takes a toll - and is not brought to justice. No wonder it seems the criminal element is in charge of "business".

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.